Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV II Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02706717
What this trial is testing

Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 93
Large-scale testing (Phase 3)Study completedNCT00038519
What this trial is testing

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Who this might be right for
HIV Infections
Abbott 16
Testing effectiveness (Phase 2)Study completedNCT02906007
What this trial is testing

Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV

Who this might be right for
TuberculosisHIV
National Institute of Allergy and Infectious Diseases (NIAID) 54
Early research (Phase 1)Study completedNCT00002313
What this trial is testing

Nystatin in HIV-Infected Patients

Who this might be right for
HIV Infections
Argus Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00029341
What this trial is testing

Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Study completedNCT00007202
What this trial is testing

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Study completedNCT00002366
What this trial is testing

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Abbott
Testing effectiveness (Phase 2)Study completedNCT00001061
What this trial is testing

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 167
Testing effectiveness (Phase 2)Study completedNCT00002227
What this trial is testing

Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Dupont Merck 60
Testing effectiveness (Phase 2)Study completedNCT00002390
What this trial is testing

The Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00002188
What this trial is testing

ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Anderson Clinical Research 27
Testing effectiveness (Phase 2)Study completedNCT00001057
What this trial is testing

The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 105
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)UnknownNCT02441231
What this trial is testing

Probiotic Visbiome for Inflammation and Translocation in HIV II

Who this might be right for
HIV-1 Infection
University Health Network, Toronto 36
Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Large-scale testing (Phase 3)Study completedNCT00424814
What this trial is testing

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 105
Early research (Phase 1)Study completedNCT00000782
What this trial is testing

A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT02038881
What this trial is testing

Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

Who this might be right for
Smallpox
Bavarian Nordic 87
Testing effectiveness (Phase 2)Study completedNCT03819114
What this trial is testing

Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

Who this might be right for
HIV InfectionsTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 122
Testing effectiveness (Phase 2)Study completedNCT00000996
What this trial is testing

Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Next Page